ResearcherBeckman Research InstituteActive in the last 2 years
Alessandro Mannucci
Matched on ORCID iD 0000-0002-1655-6762; OpenAlex author ID A5049763605. Sources: ClinicalTrials.gov.
Their work
- Papers
- 7 (first author 2, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 53
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 4 papers, 1 trial
Papers 7
- Novel approaches to liquid biopsy in pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.06.008↗
- Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41591-026-04625-x↗
- Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma First author DOI 10.1038/s41591-026-04775-y↗
- Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future. Co-author DOI 10.3322/caac.70035↗
- Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer. Co-author DOI 10.14309/ajg.0000000000002546↗
- MSH6 gene pathogenic variant identified in familial pancreatic cancer in the absence of colon cancer. Co-author DOI 10.1097/meg.0000000000001617↗
- Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Regis… Co-author DOI 10.1038/s41395-018-0414-z↗
Trials 1
- A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring Principal investigator NCT07700992↗
Closest collaborators
The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giulia Martina Cavestro · 6 shared papers, 2019–2026 · strength 1.05
- Paper Novel approaches to liquid biopsy in pancreatic cancer. DOI 10.1016/j.dld.2026.06.008↗
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Ajay Goel · 3 shared papers, 2026 · strength 1.02
- Paper Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future. DOI 10.3322/caac.70035↗
- Paper Liquid biopsy for early detection of pancreatic ductal adenocarcinoma. DOI 10.1038/s41591-026-04625-x↗
- Paper Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma DOI 10.1038/s41591-026-04775-y↗
- Marta Puzzono · 2 shared papers, 2024–2026 · strength 0.48
- Paolo Giorgio Arcidiacono · 2 shared papers, 2024–2026 · strength 0.48
- John S. Bolton · 2 shared papers, 2026 · strength 0.39
- Caiming Xu · 2 shared papers, 2026 · strength 0.39
- Mitsuro Kanda · 2 shared papers, 2026 · strength 0.39
- Derek Cridebring · 2 shared papers, 2026 · strength 0.39
- Laleh Golkar Melstrom · 2 shared papers, 2026 · strength 0.39
- Scott A. Celinski · 2 shared papers, 2026 · strength 0.39
- Eunsung Jun · 2 shared papers, 2026 · strength 0.39
- Carlos Roberto Becerra · 2 shared papers, 2026 · strength 0.39
- Douglas B. Evans · 2 shared papers, 2026 · strength 0.39
- Haiyong Han · 2 shared papers, 2026 · strength 0.39
- David L. Bartlett · 2 shared papers, 2026 · strength 0.39
- Vincent M. Chung · 2 shared papers, 2026 · strength 0.39
- Joon Oh Park · 2 shared papers, 2026 · strength 0.39
- Erkut Hasan Borazanci · 2 shared papers, 2026 · strength 0.39
- Song Cheol Kim · 2 shared papers, 2026 · strength 0.39
- Dong Shang · 2 shared papers, 2026 · strength 0.39
- Mustafa Raoof · 2 shared papers, 2026 · strength 0.39
- Daniel D. Von Hoff · 2 shared papers, 2026 · strength 0.39
- Isabella M. Frigerio · 2 shared papers, 2019–2024 · strength 0.20
- Giovanni Butturini · 2 shared papers, 2019–2024 · strength 0.20
- Alessandro Zerbi · 2 shared papers, 2019–2024 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.